Actelion Pharmaceuticals US
Actelion Pharmaceuticals US, Inc.
5000 Shoreline Court, Suite 200
South San Francisco, CA 94080
Phone: (650) 624 6900Website: https://www.actelion.us/Careers: www.actelion.us/careers/index
Latest news
- FDA Approves Opsynvi (macitentan and tadalafil) for Adults with Pulmonary Arterial Hypertension
22 March 2024 - Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Investigational Single Tablet Combination Therapy of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
30 May 2023 - Uptravi (selexipag) Receives FDA Approval for Intravenous Use in Adult Patients with Pulmonary Arterial Hypertension (PAH)
30 July 2021 - Actelion Receives FDA Approval of Tracleer (bosentan) for Use in Pediatric Patients with Pulmonary Arterial Hypertension
6 September 2017 - FDA Approves Uptravi (selexipag) for Pulmonary Arterial Hypertension
22 December 2015 - Actelion's NDA for Selexipag (Uptravi) Accepted by the FDA
3 March 2015 - Actelion Submits NDA for Selexipag (Uptravi) in Patients with Pulmonary Arterial Hypertension
23 December 2014 - FDA Approves Opsumit to Treat Pulmonary Arterial Hypertension
18 October 2013 - Actelion Announces acceptance of the New Drug Application for macitentan by the US Food and Drug Administration
14 December 2012 - Actelion submits a New Drug Application to the FDA for macitentan (Opsumit) for the treatment of patients with pulmonary arterial hypertension
22 October 2012
Drugs Associated with Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. manufactures, markets and/or distributes more than 7 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Opsumit
Generic name: macitentan Drug class: agents for pulmonary hypertension |
10 reviews | 8.2 / 10 |
|
Opsynvi
Generic name: macitentan/tadalafil Drug class: agents for pulmonary hypertension |
||
|
Tracleer
Generic name: bosentan Drug class: agents for pulmonary hypertension |
4 reviews | 9.5 / 10 |
|
Uptravi
Generic name: selexipag Drug class: agents for pulmonary hypertension |
21 reviews | 5.4 / 10 |
|
Veletri
Generic name: epoprostenol Drug class: agents for pulmonary hypertension |
2 reviews | 7.5 / 10 |
|
Ventavis
Generic name: iloprost Drug class: agents for pulmonary hypertension |
||
|
Zavesca
Generic name: miglustat Drug class: miscellaneous metabolic agents |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
